<VariationArchive VariationID="633726" VariationName="NM_181486.4(TBX5):c.593dup (p.Asn198fs)" VariationType="Duplication" Accession="VCV000633726" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2019-06-17" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="622175" VariationID="633726">
      <GeneList>
        <Gene Symbol="TBX5" FullName="T-box transcription factor 5" GeneID="6910" HGNC_ID="HGNC:11604" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="114353911" stop="114408442" display_start="114353911" display_stop="114408442" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="114791734" stop="114846246" display_start="114791734" display_stop="114846246" Strand="-" />
          </Location>
          <OMIM>601620</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_181486.4(TBX5):c.593dup (p.Asn198fs)</Name>
      <CanonicalSPDI>NC_000012.12:114394810:TTTTTT:TTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q24.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="114394810" stop="114394811" display_start="114394810" display_stop="114394811" variantLength="1" positionVCF="114394810" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="114832615" stop="114832616" display_start="114832615" display_stop="114832616" variantLength="1" positionVCF="114832615" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>N148fs</ProteinChange>
      <ProteinChange>N198fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.114832621dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.114832621dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.114394816dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.114394816dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007373.1" sequenceAccession="NG_007373" sequenceVersion="1" change="g.18632dup">
            <Expression>NG_007373.1:g.18632dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000192.3" sequenceAccession="NM_000192" sequenceVersion="3" change="c.593dup">
            <Expression>NM_000192.3:c.593dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000183.2" sequenceAccession="NP_000183" sequenceVersion="2" change="p.Asn198fs">
            <Expression>NP_000183.2:p.Asn198fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080717.4" sequenceAccession="NM_080717" sequenceVersion="4" change="c.443dup">
            <Expression>NM_080717.4:c.443dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_542448.1" sequenceAccession="NP_542448" sequenceVersion="1" change="p.Asn148fs">
            <Expression>NP_542448.1:p.Asn148fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181486.4" sequenceAccession="NM_181486" sequenceVersion="4" change="c.593dup" MANESelect="true">
            <Expression>NM_181486.4:c.593dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852259.1" sequenceAccession="NP_852259" sequenceVersion="1" change="p.Asn198fs">
            <Expression>NP_852259.1:p.Asn198fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_670" sequenceAccession="LRG_670">
            <Expression>LRG_670:g.18632dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_670t1" sequenceAccession="LRG_670t1">
            <Expression>LRG_670t1:c.593dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_670p1" sequenceAccession="LRG_670p1" change="p.Asn198fs">
            <Expression>LRG_670p1:p.Asn198fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000192.3" sequenceAccession="NM_000192" sequenceVersion="3" change="c.593dupA">
            <Expression>NM_000192.3:c.593dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_181486.4(TBX5):c.593dup (p.Asn198fs) AND Holt-Oram syndrome" Accession="RCV000782297" Version="3">
        <ClassifiedConditionList TraitSetID="2174">
          <ClassifiedCondition DB="MedGen" ID="C0265264">Holt-Oram syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_181486.4(TBX5):c.593dup (p.Asn198fs) AND Aortic valve disease 2" Accession="RCV001056565" Version="7">
        <ClassifiedConditionList TraitSetID="8857">
          <ClassifiedCondition DB="MedGen" ID="C3542024">Aortic valve disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-04" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-06-17" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16183809</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16917909</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8988164</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8857" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17368" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aortic valve disease 2</ElementValue>
                <XRef ID="MONDO:0013902" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOVD2</ElementValue>
                <XRef Type="MIM" ID="614823" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18471" />
                <XRef ID="18471" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3542024" DB="MedGen" />
              <XRef ID="MONDO:0013902" DB="MONDO" />
              <XRef Type="MIM" ID="614823" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2174" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2051" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TBX5-Related Holt-Oram Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Holt-Oram syndrome</ElementValue>
                <XRef ID="Holt-Oram+syndrome/3457" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007732" DB="MONDO" />
                <XRef ID="19092004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ventriculo-radial syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Atrio digital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiac-limb syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Heart-hand syndrome, type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOS 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HOS1</ElementValue>
                <XRef Type="MIM" ID="142900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HOS</ElementValue>
                <XRef Type="MIM" ID="142900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6666" />
                <XRef ID="6666" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Holt-Oram syndrome (HOS) is characterized by upper-limb defects, congenital heart malformation, and cardiac conduction disease. Upper-limb malformations may be unilateral, bilateral/symmetric, or bilateral/asymmetric and can range from triphalangeal or absent thumb(s) to phocomelia. Other upper-limb malformations can include unequal arm length caused by aplasia or hypoplasia of the radius, fusion or anomalous development of the carpal and thenar bones, abnormal forearm pronation and supination, abnormal opposition of the thumb, sloping shoulders, and restriction of shoulder joint movement. An abnormal carpal bone is present in all affected individuals and may be the only evidence of disease. A congenital heart malformation is present in 75% of individuals with HOS and most commonly involves the septum. Atrial septal defect and ventricular septal defect can vary in number, size, and location. Complex congenital heart malformations can also occur in individuals with HOS. Individuals with HOS with or without a congenital heart malformation are at risk for cardiac conduction disease. While individuals may present at birth with sinus bradycardia and first-degree atrioventricular (AV) block, AV block can progress unpredictably to a higher grade including complete heart block with and without atrial fibrillation.</Attribute>
                <XRef ID="NBK1111" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301290</ID>
                <ID Source="BookShelf">NBK1111</ID>
              </Citation>
              <XRef ID="392" DB="Orphanet" />
              <XRef ID="C0265264" DB="MedGen" />
              <XRef ID="MONDO:0007732" DB="MONDO" />
              <XRef Type="MIM" ID="142900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1800205" SubmissionDate="2018-07-02" DateLastUpdated="2019-06-17" DateCreated="2019-06-17">
        <ClinVarSubmissionID localKey="CV_TBX5_T26|OMIM:142900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000920816" DateUpdated="2019-06-17" DateCreated="2019-06-17" Type="SCV" Version="1" SubmitterName="Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille" OrgID="505759" OrganizationCategory="laboratory" OrgAbbreviation="CHRUL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBX5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000192.3:exon 6</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000192.3:c.593dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Holt-Oram syndrome</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="142900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4239266</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2244636" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000012.11:g.114832615_114832616insT|OMIM:142900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001138833" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBX5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.114832615_114832616insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="142900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2386464" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4910965|MedGen:CN143724" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001221015" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16183809</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16917909</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8988164</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn198Lysfs*11) in the TBX5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBX5 are known to be pathogenic (PMID: 16183809, 16917909). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Holt-Oram syndrome (PMID: 8988164). It has also been observed to segregate with disease in related individuals. This variant is also known as 1249(insA). ClinVar contains an entry for this variant (Variation ID: 633726). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBX5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.114832615_114832616insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN143724" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2244636" TraitType="Disease" MappingType="XRef" MappingValue="142900" MappingRef="OMIM">
        <MedGen CUI="C0265264" Name="Holt-Oram syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1800205" TraitType="Disease" MappingType="Name" MappingValue="Holt-Oram syndrome" MappingRef="Preferred">
        <MedGen CUI="C0265264" Name="Holt-Oram syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2386464" TraitType="Disease" MappingType="XRef" MappingValue="CN143724" MappingRef="MedGen">
        <MedGen CUI="C3542024" Name="Aortic valve disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

